- Pharm.D., University of Southern California.
Dr. Hendeles is a Professor in the College of Pharmacy and also in the Department of Pediatrics at the University of Florida. Among his current research interests are the improvement of adherence to asthma medications and delivery of inhaled drugs to young children. He is a consultant to FDA’s Pulmonary Division, and previously served on the Coordinating Committee of NIH’s Asthma Education Program, as well as CDC’s Expert Panel on Asthma Guidelines for Emergency Medical Services. Dr. Hendeles provides advice on drug therapy and teaches in the Pediatric Pulmonary Clinic at the University of Florida.
- American Society of Health-System Pharmacists
- American Academy of Allergy and Immunology
- American College of Clinical Pharmacy
- American Thoracic Society
- American Pharmacists Association
- Pediatric Pharmacy Advocacy Group
Hendeles L, Khan YR, Shuster JJ, Chesrown SE, Abu-Hasan M. Omalizumab therapy for asthma patients with poor adherence to inhaled corticosteroid therapy. Ann Allergy Asthma Immunol 2015 Jan
ElMallah MK, Khan Y, Hochhaus G, Shuster JJ, Hendeles L. Systemic exposure to fluticasone MDI delivered through anti-static chambers. J Allergy Clin Immunol 2011 (in press).
Blake K, Mehta R, Spencer T, Kunka RL, Hendeles L. Bioavailability of inhaled fluticasone propionate via chambers/masks in young children. Eur Respir J 2011 (in press).
Prabhakaran S, Shuster J, Ahrens R, Hendeles L. Methacholine challenge as a clinical bioassay of pulmonary delivery of a long-acting β2-adrenergic agonist. Pharmacotherapy 2011 May;31(5):449-57.
Hendeles L, Borowitz D. Pharmacotherapy update: pancreatic enzyme products. Pediatr Asthma Allergy Immunol 2010 Dec;23(4):291-4.
Adams WP, Ahrens RC, Chen M-L, Christopher D, Chowdhury BA, Conner DP, Dalby R, Fitzgerald K, Hendeles L, Hickey AJ, Hochhaus G, Laube BL, Lucas P, Lee SL, Lyapustina S, Li B, O’Connor D, Parkins DA, Peri P, Pitcairn GR, Riebe M, Roy P, Shah T, Singh GJP, Sharp SS, Suman JD, Weda M, Woodcook J, Yu L. Demonstrating bioequivalence of locally acting orally inhaled drug products (OIPs): workshop summary report. J Aerosol Med Pulm Drug Deliv 2010 Feb;23(4):1-29.
Hendeles L. Advocating for patients through clinical research. J Pediatr Pharmacol Ther 2008;13:4-16.
Hendeles L, Sorkness CA. Anti-immunoglobulin E therapy with omalizumab for asthma. Ann Pharmacother 2007 Sep;41(9):1397-410.
Hatton RC, Winterstein AG, McKelvey RP, Shuster J, Hendeles L. Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann Pharmacother 2007 Mar;41(3):381-90.
Hendeles L, Colice GL, Meyer RJ. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med, 2007 Mar 29;356(13):1344-51.
Full Publication List via PubMed RSS feed